Blockchain Registration Transaction Record

AXIM & JK Medical Partner to Bring Rapid Eye Diagnostics to Latin America

AXIM Biotechnologies partners with JK Medical to distribute TearScan® ocular diagnostics across 7 Latin American countries, revolutionizing dry eye and allergy diagnosis.

This partnership directly impacts millions of Latin Americans suffering from dry eye disease and ocular allergies by making advanced diagnostic tools more accessible. For patients, this means faster, more accurate diagnoses and targeted treatments that address the root cause of their eye conditions rather than just managing symptoms. For healthcare providers, it represents a significant advancement in clinical capabilities, enabling differential diagnosis at the point of care and reducing the time between initial consultation and effective treatment. Given that dry eye affects approximately 350 million people globally with tens of millions in Latin America alone, this collaboration addresses a substantial unmet medical need in a region where specialized diagnostic tools have traditionally been limited. The availability of these rapid tests could transform standard of care for ocular conditions that significantly impact quality of life and productivity.